重慶鋼鐵股份(01053.HK):實際控制人持股增至23.51%
重慶鋼鐵股份(01053.HK)公佈,從公司實際控制人中國寶武獲悉,於本星期三(22日),中國寶武通過大宗交易方式,受讓重慶環亞建材持有的1.3億股公司股票,佔總股本的1.46%,每股成交價2.62元人民幣。
此次權益變動前,中國寶武作爲公司實際控制人,通過直接持有重慶長壽鋼鐵40%股權並與重慶戰略性新興產業股權投資基金合夥企業達成一致行動協議取得長壽鋼鐵的控制權,從而間接控制公司總股本23.51%;本次權益變動後,中國寶武合計控制公司總股本24.97%,其中,中國寶武直接持有公司1.46%股份、間接控制公司23.51%股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.